Oldest pages

Showing below up to 50 results in range #1,301 to #1,350.

1301. 34. Intravascular radiologic interventions II. Interventional radiologic treatment of bleeding, vasoocclusive techniques (embolization, sclerotisation).‏‎ (21:03, 4 January 2024)
1302. 35. Image-guided biopsies. Cyst puncture, drainage (biliary, renal, bladder etc.)‏‎ (21:03, 4 January 2024)
1303. 36. Radiologic interventions in tumor treatment (Tumor ablation techniques. Selective cytostatic treatment, chemoembolization).‏‎ (21:04, 4 January 2024)
1304. 37. The fundamentals of nuclear medicine imaging. Types of radiation, applications.‏‎ (21:05, 4 January 2024)
1305. 38. Advantages of hybrid techniques (SPECT/CT, PET/CT).‏‎ (21:06, 4 January 2024)
1306. 39. Radioisotope diagnostics of pulmonary embolism (perfusion and inhalation). Radioisotope methods in pulmonary malignancies.‏‎ (21:06, 4 January 2024)
1307. 40. Radioisotope examination of myocardial perfusion (transient and permanent ischaemia, viability). Radioisotope examination of left ventricle pump function and wall motion problems.‏‎ (21:07, 4 January 2024)
1308. 41. Radioisotope diagnostics of thyroid diseases and parathyroid diseases.‏‎ (21:07, 4 January 2024)
1309. 42. Nuclear medicine methods in childhood (kidney, bone, 123I-MIBG scintigraphy).‏‎ (21:07, 4 January 2024)
1310. 43. Radioisotope diagnostics in breast and gynecologic tumors. The significance of sentinel lymph node scintigraphy.‏‎ (21:08, 4 January 2024)
1311. 44. Brain perfusion examinations in nuclear medicine (indications, radiopharmaceuticals, imaging).‏‎ (21:08, 4 January 2024)
1312. 45. Nuclear medicine examinations in gastroenterology.‏‎ (21:08, 4 January 2024)
1313. 47. Indications of bone scintigraphy. The significance and indications of 3-phase bone scintigraphy.‏‎ (21:09, 4 January 2024)
1314. 48. Radioiodine therapy in the diseases of the thyroid gland.‏‎ (21:09, 4 January 2024)
1315. 49. Radionuclide therapy of neuroendocrine and neuroectodermal tumors.‏‎ (21:10, 4 January 2024)
1316. 62. General characteristics and types of chronic obstructive lung diseases‏‎ (19:35, 12 January 2024)
1317. 1. Pentose phosphate pathway‏‎ (16:47, 15 January 2024)
1318. Obesity‏‎ (16:53, 15 January 2024)
1319. 1. Importance of non-communicable diseases in developed countries (mortality, morbidity, trends)‏‎ (16:55, 15 January 2024)
1320. Purpose of investigation‏‎ (11:58, 16 January 2024)
1321. Screening‏‎ (11:58, 16 January 2024)
1322. 1. Purpose of laboratory test requests (screening, diagnosis, differential-diagnosis, validation, monitoring).‏‎ (11:59, 16 January 2024)
1323. 2. Patient preparation before sampling. Proper method to carry out blood (venous, capillary) and urine collection. Type of tubes.‏‎ (12:11, 16 January 2024)
1324. 3. Reference values and ranges, specificity, sensitivity and predictive value of laboratory tests.‏‎ (12:14, 16 January 2024)
1325. 11. Risk factors of malignant diseases‏‎ (13:06, 16 January 2024)
1326. 25. Epidemiology and prevention of ulcer disease‏‎ (13:08, 16 January 2024)
1327. Test characteristics‏‎ (13:45, 16 January 2024)
1328. 12. Screening of malignant diseases‏‎ (14:12, 18 January 2024)
1329. Point of care test‏‎ (14:46, 18 January 2024)
1330. 5. Bedside/point of care tests (POCT) and their informational value‏‎ (14:46, 18 January 2024)
1331. 31. Pathogenesis and clinicopathology of tuberculosis‏‎ (21:49, 25 January 2024)
1332. Sodium‏‎ (20:51, 28 January 2024)
1333. 6. Disorders of water and sodium homeostasis‏‎ (20:53, 28 January 2024)
1334. Hyponatraemia‏‎ (20:26, 30 January 2024)
1335. Hypernatraemia‏‎ (20:35, 30 January 2024)
1336. Potassium‏‎ (21:13, 31 January 2024)
1337. Hypokalaemia‏‎ (21:23, 31 January 2024)
1338. 7. Disorders of potassium balance‏‎ (21:24, 31 January 2024)
1339. Hyperkalaemia‏‎ (21:29, 31 January 2024)
1340. 20. Nosocomial infections. Sterilization, disinfection‏‎ (20:22, 19 February 2024)
1341. Ventricular arrhythmia‏‎ (17:39, 20 February 2024)
1342. Hypoventilation‏‎ (21:05, 28 February 2024)
1343. Respiratory failure‏‎ (21:09, 29 February 2024)
1344. 8. Laboratory findings in metabolic type changes of the acid/base balance‏‎ (22:00, 29 February 2024)
1345. 9. Laboratory findings in respiratory type changes of the acid/base balance‏‎ (20:06, 1 March 2024)
1346. Hypocalcaemia‏‎ (15:44, 4 March 2024)
1347. Hypercalcaemia‏‎ (16:40, 4 March 2024)
1348. Hepatitis E‏‎ (22:47, 15 March 2024)
1349. Thoracic empyema‏‎ (21:04, 18 March 2024)
1350. B7. Prenatal diagnostics I. (invasive methods)‏‎ (19:05, 21 March 2024)